Pharmaceutical giant Pfizer, Inc. on Tuesday reported a 10 percent decline in profit for the second quarter from last year, on lower revenues that were negatively impacted by a strong U.S. dollar. However, both revenue and adjusted earnings per share for the quarter that beat analysts’ expectations. Looking ahead, the company raised its financial outlook for fiscal 2015.